Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

ADMA holding history

Adma Biologics, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADMA overviewAll 13F holders of ADMAFull Q2 2026 holdings

Shares (Q2 2026)
1,316,568
Value
$11.0M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ADMA by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,316,568$11.0M<0.1%−513,102−28.0%ReducedHolders
Q1 20261,829,670$16.5M<0.1%+1,829,670NewHolders
Q4 20250$00.0%−164,125−100.0%Sold outHolders
Q3 2025164,125$2.41M<0.1%−125,060−43.2%ReducedHolders
Q2 2025289,185$5.27M<0.1%+41,699+16.8%AddedHolders
Q1 2025247,486$4.91M<0.1%−355,281−58.9%ReducedHolders
Q4 2024602,767$10.3M<0.1%+294,685+95.7%AddedHolders
Q3 2024308,082$6.16M<0.1%−108,339−26.0%ReducedHolders
Q2 2024416,421$4.66M<0.1%+228,077+121.1%AddedHolders
Q1 2024188,344$1.24M<0.1%−583,127−75.6%ReducedHolders
Q4 2023771,471$3.49M<0.1%−433,177−36.0%ReducedHolders
Q3 20231,204,648$4.31M<0.1%+224,696+22.9%AddedHolders
Q2 2023979,952$3.62M<0.1%+444,455+83.0%AddedHolders
Q1 2023535,497$1.77M<0.1%+493,424+1,172.8%AddedHolders
Q4 202242,073$163.2K<0.1%−250,890−85.6%ReducedHolders
Q3 2022292,963$712.0K<0.1%+292,963NewHolders
Q2 20220$00.0%−148,080−100.0%Sold outHolders
Q1 2022148,080$271.0K<0.1%+43,520+41.6%AddedHolders
Q4 2021104,560$147.0K<0.1%+92,773+787.1%AddedHolders
Q3 202111,787$13.0K<0.1%−120,800−91.1%ReducedHolders
Q2 2021132,587$212.0K<0.1%+96,397+266.4%AddedHolders
Q1 202136,190$64.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.